United States Radiofrequency Ablation Devices Market was valued at US$ 1,296.97 million in 2023 and is projected to attain a market size of US$ 3,312.40 million by 2032 at a CAGR of 11.24% during the forecast period 2024–2032.
Europe in-vitro diagnostics market was valued at US$ 24.13 billion in 2022 and is projected to attain a market size of US$ 35.22 billion by 2031 at a CAGR of 4.5% during the forecast period 2023–2031.
North America ECG patch and Holter monitoring market was valued at US$ 1,161.4 million in 2022 and is projected to surpass the market valuation of US$ 4,413.3 million by 2031 at a CAGR of 15.99% during the forecast period 2023–2031.
Japan pharmaceutical manufacturing market was valued at US$ 31.74 billion in 2022 and is projected to reach market size of US$ 53.90 billion by 2031 at a CAGR of 6.06% during the forecast period 2023–2031.
Global pharmaceutical manufacturing market was valued at US$ 785.8 billion in 2022 and is projected to reach market size of US$ 2,103.2 billion by 2031 at a CAGR of 11.56% during the forecast period 2023–2031.
Global ultrasound devices market was valued at US$ 7,197.7 million in 2022 and is projected to reach US$ 10,919.6 million by 2031 at a CAGR of 4.74% during the forecast period 2023–2030 during the forecast period 2023–2031.
Global digital surgery technologies market was valued at US$ 468.6 million in 2022 and is projected to attain a valuation of US$ 4,143.1 by 2031 at a CAGR of 27.4% during the forecast period 2023–2031.
The global radiation protection apron market was valued at US$ 134.5 billion in 2022 and is projected to generate a revenue of over US$ 253.3 billion by 2031 at a CAGR of 7.29% during the forecast period 2023–2031.
Global breast cancer screening market was valued at US$ 7,461.8 million in 2022 and is projected to surpass market size of US$ 16,340.5 million by 2031 at a CAGR of 9.1% during the forecast period, 2023–2031.